Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer;”
Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00004096. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT06514027. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06895941. IPD Sharing: NO. Countries: 1. Publications: 0.
A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03616522. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00003002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01024712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.
ClinicalTrials.gov study NCT02109549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00379717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 I
ClinicalTrials.gov study NCT05607550. IPD Sharing: UNDECIDED. Countries: 19. Publications: 0.
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib
ClinicalTrials.gov study NCT05948462. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
ClinicalTrials.gov study NCT07207395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prediction of Immunotherapeutic Effect of Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04427475. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02202655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
ClinicalTrials.gov study NCT04790682. IPD Sharing: YES. Countries: 1. Publications: 0.
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
ClinicalTrials.gov study NCT07198841. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03851445. IPD Sharing: NO. Countries: 1. Publications: 0.
Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observation
ClinicalTrials.gov study NCT06310915. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
ClinicalTrials.gov study NCT05486650. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
ClinicalTrials.gov study NCT00387374. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01496742. IPD Sharing: Not stated. Countries: 13. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.